Results
1 -
10 of
11Development of a UPLC-ESI-MS/MS method for the determination of larotaxel in beagle dog plasma: application to the pharmacokinetic study, Analytical and Bioanalytical Chemistry A phase I study of larotaxel (XRP9881) administered in combination with carboplatin in chemotherapy-na??ve patients with stage IIIB or stage IV non-small cell lung cancer, Cancer Chemotherapy and Pharmacology Phase I study of larotaxel administered as a 1-h intravenous infusion every 3??weeks to Japanese patients with advanced solid tumours, Cancer Chemotherapy and Pharmacology Pharmacokinetics and tissue distribution of larotaxel in rats: comparison of larotaxel-loaded microsphere with larotaxel-solution, Cancer Chemotherapy and Pharmacology New Microtubule Inhibitors in Breast Cancer, Current Breast Cancer Reports Novel Cytotoxic Agents in the Treatment of Metastatic Breast Cancer, Current Breast Cancer Reports Systemic Therapy of Advanced Urothelial Cancer, Current Treatment Options in Oncology Larotaxel + cisplatin combo shows first-line promise in NSCLC, Inpharma Weekly